Elizabeth Warren, Massachusetts' newest and now senior senator, toured Genzyme in Framingham on Friday and met with the company's CEO, David Meeker.
After the tour, Warren commented on the importance of investing in Massachusetts' infrastructure to ensure companies like Genzyme are able to succeed. Genzyme opened a new $330 million facility in 2012 in Framingham.
"This [company] is here in Framingham because of all the investments we in Massachusetts make," Warren said. "Those are the investments we make to make this happen."
Meeker commented on the importance of Warren coming to the Genzyme facility.
"I'm really glad Elizabeth is here, Meeker said. "It is important to bring attention to Framingham and MetroWest and the jobs we create."
Genzyme, a Sanofi subsidiary, is the third-largest biotechnology company in the world.
Genzyme's newest facility's sole purpose is to produce a
Warren had found out minutes before the tour that her former opponent,
"It's a very personal decision about whether or not to take on a big race like that and I wish him the very best," Warren said.
along with Framingham State Reps. Chris Walsh and Tom Sannicandro were also in attendance.